Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Gerresheimer Expects Around 9% Growth in 2016


News provided by

Gerresheimer AG

11 Feb, 2016, 07:33 GMT

Share this article

Share toX

Share this article

Share toX

DUESSELDORF, Germany, February 11, 2016 /PRNewswire/ --

 

  • Revenues in financial year 2015 up 6.8% to EUR 1,377.2m 
  • Adjusted EBITDA climbs to EUR 277.9m  
  • Adjusted earnings per share rise 18.0% to EUR 3.41 
  • Proposed dividend of EUR 0.85 per share (2014: EUR 0.75 per share) 
  • Centor acquisition, sale of glass tubing business and refinancing successfully completed 
  • Approximately 9% revenue growth expected in 2016, with 4% to 5% on organic basis 
  • Adjusted EBITDA expected for 2016 at approximately EUR 320m 

Gerresheimer AG, one of the leading partners to the pharma and healthcare industry worldwide, brought financial year 2015 to a successful close and sees strong growth prospects for the years ahead. "2015 was not only a successful but also an important year for us. In Centor, we successfully acquired a market-leading and profitable company in the USA. Similarly important was the sale of the glass tubing production activities, with which we further sharpened our focus on pharmaceutical packaging and made our business less capital-intensive. We are successfully implementing our strategy, and I look forward with great confidence to the years ahead," said Uwe Röhrhoff, CEO of Gerresheimer AG. 

Pharmaceutical packaging manufacturer Gerresheimer boosted revenues by 6.8% to EUR 1,377.2m in financial year 2015 (December 1, 2014 to November 30, 2015). On an organic basis, revenues increased by 1.5%, within the 1% to 3% target corridor. Notable revenue growth was generated with pharmaceutical plastic packaging as well as products for safe and simple drug delivery such as insulin pens, skin-prick aids for diabetics and asthma inhalers. Business with pharmaceutical primary packaging glass picked up in the course of the year after a slow start in the USA. The market for premium cosmetic glass packaging developed well, largely driven by the trend toward elaborate design and the associated finishing processes. Revenues with laboratory glassware, which is primarily sold in the USA, increased solely as a result of exchange rate changes. At constant exchange rates revenues showed a slight decrease.

Adjusted EBITDA went up in financial year 2015 to EUR 277.9m, or EUR 271.9m on a constant exchange rate basis. Excluding the Centor acquisition, adjusted EBITDA was EUR 262.4m, squarely within the target corridor of EUR 255m to EUR 265m. Compared with a prior-year figure of 19.6%, the adjusted EBITDA margin was above the 20% mark, at 20.2%. Backed by improved operating earnings power and the proceeds from the sale of the glass tubing business, net income grew by 54.6% to EUR 112.7m. Adjusted earnings per share rose 18.0% to EUR 3.41 compared with a 2014 figure of EUR 2.89.

Gerresheimer successfully completed two key transactions in financial year 2015. With the acquisition of Centor, the Company realized its long-term goal of occupying a stronger presence in the plastic pharmaceutical packaging segment in the USA. Centor is the market leader in plastic containers used by American pharmacies to package prescription tablets. In addition, Gerresheimer sold its glass tubing production activities, entered into a long-term supply contract for this intermediary product and established a joint venture for future innovation in the pharmaceutical glass segment. Prior to the two transactions, the overall financing arrangement from 2011 was replaced in June 2015 with a EUR 450m revolving credit facility. The Centor acquisition was primarily funded out of the successful EUR 425m debt issue in November 2015. Leverage-the ratio of net financial debt to adjusted EBITDA-stood at 2.9 as of the end of November 2015 compared with a prior-year figure of 1.7. The Company aims to bring leverage back down as soon as possible.

Gerresheimer's capital expenditure in financial year 2015 was EUR 125.8m (2014: EUR 126.6m), or 9.0% of revenues at constant exchange rates and excluding Centor. The target for capital expenditure was 9% to 10% of revenues. Gerresheimer is further expanding production capacity for drug delivery systems such as insulin pens and asthma inhalers, especially in the USA and Czech Republic. Late summer 2015 brought an expansion and improvements at the moulded glass plant in Chicago, USA. The global program of modernizing and standardizing injection vial production machinery was successfully continued. A new production building for injection vials and ampoules was completed in India. Production there is set to start up at the end of 2016.

Outlook 

Gerresheimer's expectations for financial year 2016 are set out in the following, in each case based on constant exchange rates. For the US dollar-which has the largest currency impact on the Group currency and will now account for about a third of Group revenues in 2016 - Gerresheimer has assumed an exchange rate of approximately USD 1.12 to EUR 1.00.

In financial year 2016, the Company anticipates Group revenues of around EUR 1.5bn (plus or minus EUR 25m) on a constant exchange rate basis. The Group revenues of EUR 1.5bn correspond to revenue growth of about 9% at constant exchange rates compared with revenues in financial year 2015, and organic revenue growth of between 4% and 5%. Gerresheimer expects adjusted EBITDA to increase to approximately EUR 320m (plus or minus EUR 10m) in financial year 2016. Capital expenditure in financial year 2016 is anticipated to be no more than roughly 8% of revenues at constant exchange rates, and thus at the lower end of the previous guidance for financial years 2016 to 2018 of between 8.0% and 9.0% of revenues at constant exchange rates.

Major steps were taken in 2015 to make the business less capital intensive. The sale of the glass tubing business and the permanent closure of the moulded glass plant in Millville Gerresheimer significantly reduced the number of furnaces operated by a total of eight to thirteen. At the same time, the Company anticipates a decrease in the ratio of net working capital to revenues because, among other factors, buying finished glass tubes in line with requirements following the sale of the glass tubing business means that less inventory has to be held overall. Average net working capital is forecast to improve in 2016 by about two percentage points to around 17% of revenues at constant exchange rates.

In addition, the Company confirms its indication for the financial years 2016 to 2018, in each case stated at constant exchange rates and assuming a US dollar exchange rate of USD 1.12 to EUR 1.00. Gerresheimer is aiming for average annual organic revenue growth of 4% to 5% for the period from 2016 to 2018. For the adjusted EBITDA margin, the Group has set a target of approximately 22% for financial year 2018. In order to meet these targets, Gerresheimer will in all probability require significantly lower annual capital expenditure of the order of only about 8% of revenues at constant exchange rates.

Dividend 

At the Annual General Meeting on April 28, 2016, the Management Board and Supervisory Board will be jointly proposing that a dividend of EUR 0.85 per share be paid out for financial year 2015. This represents an increase of 13% against the prior-year dividend. The dividend ratio amounts to 25% of adjusted net income after non-controlling interests.

The Annual Report is available here:

http://www.gerresheimer.com/en/investor-relations/reports

- Cross reference: The full press release including tables is available at http://www.presseportal.de/nr/9072 -

Gerresheimer AG
Klaus-Bungert-Strasse 4
40468 Düsseldorf
Germany

Jens Kürten
Group Senior Director Communication & Marketing
Phone +49-211-6181-250
Telefax +49-211-6181-241
E-Mail j.kuerten@gerresheimer.com
Internet http://www.gerresheimer.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.